Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8460704 | BOEHRINGER INGELHEIM | Extended release formulation of nevirapine |
Mar, 2029
(5 years from now) |
Market Authorisation Date: 25 March, 2011
Treatment: Treatment of hiv-1 by once daily administration
Dosage: TABLET, EXTENDED RELEASE;ORAL
3
United States
2
Peru
1
Colombia
1
Ecuador
1
Australia
1
EA
1
Korea, Republic of
1
Canada
1
New Zealand
1
Denmark
1
Spain
1
Tunisia
1
Uruguay
1
Chile
1
Ukraine
1
Poland
1
Japan
1
Morocco
1
Hong Kong
1
Mexico
1
Argentina
1
Brazil
1
China
1
South Africa
1
Hungary
1
Taiwan
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic